The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
出版年份 2017 全文链接
标题
The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
作者
关键词
-
出版物
Brain and Behavior
Volume 7, Issue 6, Pages e00696
出版商
Wiley
发表日期
2017-05-09
DOI
10.1002/brb3.696
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects
- (2016) Xiao Hu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
- (2016) Joseph Menzin et al. JOURNAL OF MANAGED CARE PHARMACY
- Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study
- (2015) Xiao Hu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
- (2015) Maria Pia Amato et al. CNS DRUGS
- Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
- (2015) Ludwig Kappos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy outcomes in patients exposed to interferon beta-1b: Table 1
- (2014) Rebecca S Romero et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
- (2014) Bernd C Kieseier et al. Multiple Sclerosis Journal
- A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
- (2011) Xiao Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In Vivo Pharmacology and Toxicology Evaluation of Polyethylene Glycol-Conjugated Interferon -1a
- (2011) X. Hu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis
- (2010) Stephanie C. Steinberg et al. CLINICAL DRUG INVESTIGATION
- The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
- (2010) V. Devonshire et al. EUROPEAN JOURNAL OF NEUROLOGY
- Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
- (2009) M. Trojano et al. ANNALS OF NEUROLOGY
- Emerging PEGylated drugs
- (2009) Jung Seok Kang et al. EXPERT OPINION ON EMERGING DRUGS
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More